Skip to contentA
Accendra Health Inc
A
ACHAccendra Health Inc Q2 2020 · 10-Q
Revenue$1.81B$1.81B−23.9% vs Q2 2019 Net Income-$55.63M-$55.63MN/M vs Q2 2019 EPS Diluted-$0.91-$0.91N/M vs Q2 2019 Gross Profit$269,407,000−6.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR
Operating Cash Flowderived$57,003,000−36.6% Free Cash Flowderived$53,041,000−34.2% Margins · derivedGross margin14.9%+2.8 pt vs Q2 2019
Operating margin1.2%+0.6 pt vs Q2 2019
Net margin-3.1%−2.6 pt vs Q2 2019
ended Jun 30, 2020 · filed Aug 5, 2020 · 36 d after period end